head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2022, vol. 28, issue3
Subject Area: Medicine
DOI: 10.5272/jimab.2022283.4474
Published online: 27 July 2022

Original article
J of IMAB. 2022 Jul-Sep;28(3):4474-4479
Konstantin D. GospodinovORCID logo Corresponding Autoremail, Yoana M. TodorovaORCID logo, Snezhana T. TishevaORCID logo,
Department of Cardiology, Sector Internal Medicine, Medical Faculty, Medical University Pleven, Bulgaria.

There is an increasing HF population resulting from the higher number of MI survivors and the widespread presence of diabetes, hypertension, CHD (Chronic Heart Filure), obesity and other chronic conditions. Cardiac dysfunction is the main factor that leads to reduced physical activity in patients with HF. The alternations in skeletal musculature often are present in the background of HF and can contribute to fatigue and dyspnea. Sarcopenia is a reduction in muscle mass and force, and it is right to say that it is one of the signs of “getting old”.The modern views on sarcopenia are that it is an outcome of many medical, behavioral and ecological factors, which are common in older people. Together with a sedentary lifestyle, it can be the main reason for disability in the late stages of human life. In our study, we examined the significance of reduced skeletal muscle tissue on mortality and survival of patients with diagnosed HF. The results showed that sarcopenia is a significant contributing factor for increased mortality [p = 0,022] and reduced survival rates [p = 0,033] in patients with HF II – IV class by NYHA. As a secondary goal we found there is significant correlation between age and sarcopenia [R²Linear = 0,057].

Keywords: Chronic Heart Failure (CHF), Sarcopenia, Ageing, Mortality,

pdf - Download FULL TEXT /PDF 1767 KB/
Please cite this article as: Gospodinov KD, Todorova YM, Tisheva ST. The impact of age-related sarcopenia on survival and mortality in patients with Chronic Heart Failure. J of IMAB. 2022 Jul-Sep;28(3):4474-4479. DOI: 10.5272/jimab.2022283.4474

Corresponding AutorCorrespondence to: Dr. Konstantin D. Gospodinov, Department of Cardiology, UMHAT “Dr Georgi Stranski”, Pleven; 8a, Georgi Kochev str., 2nd floor, Department of Cardiology; Pleven, Bulgaria; E-mail: drkdg@abv.bg

1. Booth FW, Chakravarthy MV, Spangenburg EE. Exercise and gene expression: physiological regulation of the human genome through physical activity. J Physiol. 2002 Sep 1;543(Pt 2):399-411. [PubMed]
2. Lena A, Anker MS, Springer J. Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science. Int J Mol Sci. 2020 Sep 8;21(18):6549. [PubMed]
3. usumeci G. Sarcopenia and Exercise “The State of the Art”. J Funct Morphol Kinesiol. 2017 Nov 4;2(4):40. [Crossref]
4. Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V, et al. Sarcopenia and Heart Failure. Nutrients. 2020 Jan 14;12(1):211. [PubMed]
5. Gonzalez E, Messi ML, Delbono O. The specific force of single intact extensor digitorum longus and soleus mouse muscle fibers declines with aging. J Membr Biol. 2000 Dec 1;178(3):175-83. [PubMed]
6. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001 Feb 1;153(3):242-50. [PubMed]
7.Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, et al. change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002 Dec;50(12):1947-54. [PubMed]
8.Ivey FM, Roth SM, Ferrell RE, Tracy BL, Lemmer JT, Hurlbut DE, et al. Effects of age, gender, and myostatin genotype on the hypertrophic response to heavy resistance strength training. J Gerontol A Biol Sci Med Sci. 2000 Nov;55(11):M641-8. [PubMed]
9. Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, et al. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail. 2018 Nov;20(11):1580-1587. [PubMed]
10. DeVol DL, Rotwein P, Sadow JL, Novakofski J, Bechtel PJ. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol. 1990 Jul;259(1 Pt 1):E89-95. [PubMed]
11. Ji LL. Exercise at old age: does it increase or alleviate oxidative stress? Ann NY Acad Sci. 2001 Apr;928:236-47. [PubMed]
12. Jagoe RT, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care. 2001 May;4(3):183-90. [PubMed]
13.Carbone S, Billingsley HE, Rodriguez-Miguelez P, Kirkman DL, Garten R, Franco RL, et al. Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia. Curr Probl Cardiol. 2020 Nov;45(11):100417. [PubMed]
14. Philippou A, Xanthis D, Chryssanthopοulos C, Maridaki M, Koutsilieris M. Heart Failure-Induced Skeletal Muscle Wasting. Curr Heart Fail Rep. 2020 Oct;17(5):299-308. [PubMed]
15. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, et al. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008 Jun 4;299(21):2533-42. [PubMed].

Received: 10 January 2022
Published online: 27 July 2022

back to Online Journal